Acute malaria infection after atovaquone-proguanil prophylaxis.
作者信息
Minta Anna A, Tan Kathrine R, Mace Kimberly E, Arguin Paul M
机构信息
Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Malaria Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
出版信息
J Travel Med. 2017 Mar 1;24(2). doi: 10.1093/jtm/taw080.
Abstract
摘要
相似文献
1
Acute malaria infection after atovaquone-proguanil prophylaxis.阿托伐醌-氯胍预防后发生急性疟疾感染。
J Travel Med. 2017 Mar 1;24(2). doi: 10.1093/jtm/taw080.
2
Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.阿托伐醌/氯胍：用于预防恶性疟原虫疟疾的应用综述
Drugs. 2003;63(6):597-623. doi: 10.2165/00003495-200363060-00006.
3
Atovaquone + proguanil: new preparation. Second-line antimalarial combination.阿托伐醌+氯胍：新制剂。二线抗疟联合用药。
Prescrire Int. 2002 Oct;11(61):131-6.
4
Atovaquone and proguanil hydrochloride for prophylaxis of malaria.阿托伐醌和盐酸氨丙啉用于疟疾预防。
J Travel Med. 1999 May;6 Suppl 1:S21-7.
5
[symbol: see text] Atovaquone + proguanil for malaria prophylaxis.[符号：见正文] 阿托伐醌+氯胍用于疟疾预防。
Drug Ther Bull. 2001 Oct;39(10):73-5.
6
Atovaquone and proguanil hydrochloride for treatment of malaria.阿托伐醌和盐酸氨苯砜用于疟疾治疗。
J Travel Med. 1999 May;6 Suppl 1:S18-20.
7
Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.恶性疟原虫细胞色素b基因的突变与接受阿托伐醌-氯胍治疗的疟疾患者中寄生虫复发延迟有关。
Malar J. 2008 Nov 20;7:240. doi: 10.1186/1475-2875-7-240.
8
Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.阿托伐醌-氯胍与氯喹-氯胍用于非免疫旅行者疟疾预防的随机双盲研究。马拉隆国际研究团队。
Lancet. 2000 Dec 2;356(9245):1888-94. doi: 10.1016/s0140-6736(00)03260-8.
9
Mefloquine for preventing malaria during travel to endemic areas.甲氟喹用于在前往疟疾流行地区旅行期间预防疟疾。
Cochrane Database Syst Rev. 2017 Oct 30;10(10):CD006491. doi: 10.1002/14651858.CD006491.pub4.
10
Vivax Malaria Chemoprophylaxis: The Role of Atovaquone-Proguanil Compared to Other Options.间日疟化学预防：阿托伐醌-伯氨喹与其他选择的比较。
Clin Infect Dis. 2018 May 17;66(11):1751-1755. doi: 10.1093/cid/cix1077.
本文引用的文献
1
Effectiveness of twice a week prophylaxis with atovaquone-proguanil (Malarone®) in long-term travellers to West Africa.在长期前往西非的旅行者中，每周两次使用阿托伐醌-磺胺多辛（科泰复®）预防的效果。
J Travel Med. 2016 Sep 13;23(6). doi: 10.1093/jtm/taw064. Print 2016 Jun.
2
Novel Mutation in Cytochrome B of Plasmodium falciparum in One of Two Atovaquone-Proguanil Treatment Failures in Travelers Returning From Same Site in Nigeria.在从尼日利亚同一地点返回的旅行者中，两种阿托伐醌-丙氧喹啉治疗失败的案例中，疟原虫细胞色素 B 出现新突变。
Open Forum Infect Dis. 2014 Aug 5;1(2):ofu059. doi: 10.1093/ofid/ofu059. eCollection 2014 Sep.
3
Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa.短程阿托伐醌-磺胺多辛预防剂在前往撒哈拉以南非洲旅行者中的效果。
J Travel Med. 2014 Mar-Apr;21(2):82-5. doi: 10.1111/jtm.12088. Epub 2013 Dec 3.
4
Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.阿托伐醌-磺胺多辛单剂在人体疟疾挑战模型中对恶性疟原虫疟疾的化学预防提供持久保护。
Clin Infect Dis. 2012 Jan 15;54(2):232-9. doi: 10.1093/cid/cir770. Epub 2011 Nov 3.
5
Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).阿托伐醌-氯胍：美国疾病控制与预防中心疟疾化学预防专家会议（II）报告。
Am J Trop Med Hyg. 2007 Feb;76(2):208-23.
Zotero 插件